| ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease PD James, NT Connell, B Ameer, J Di Paola, J Eikenboom, N Giraud, ... Blood advances 5 (1), 280-300, 2021 | 371 | 2021 |
| Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia L Noetzli, RW Lo, AB Lee-Sherick, M Callaghan, P Noris, A Savoia, ... Nature genetics 47 (5), 535-538, 2015 | 343 | 2015 |
| Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome WHA Kahr, J Hinckley, L Li, H Schwertz, H Christensen, JW Rowley, ... Nature genetics 43 (8), 738-740, 2011 | 301 | 2011 |
| Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis SM Jobe, KM Wilson, L Leo, A Raimondi, JD Molkentin, SR Lentz, ... Blood, The Journal of the American Society of Hematology 111 (3), 1257-1265, 2008 | 244 | 2008 |
| TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging P Davizon-Castillo, B McMahon, S Aguila, D Bark, K Ashworth, A Allawzi, ... Blood, The Journal of the American Society of Hematology 134 (9), 727-740, 2019 | 242 | 2019 |
| Factor XIII activity mediates red blood cell retention in venous thrombi MM Aleman, JR Byrnes, JG Wang, R Tran, WA Lam, J Di Paola, ... The Journal of clinical investigation 124 (8), 3590-3600, 2014 | 234 | 2014 |
| Diagnostic approach to von Willebrand disease C Ng, DG Motto, J Di Paola Blood, The Journal of the American Society of Hematology 125 (13), 2029-2037, 2015 | 211 | 2015 |
| Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor VH Flood, JC Gill, PA Morateck, PA Christopherson, KD Friedman, ... Blood, The Journal of the American Society of Hematology 116 (2), 280-286, 2010 | 181 | 2010 |
| Low Platelet 2β1 Levels in Type I von Willebrand Disease Correlate With Impaired Platelet Function in a High Shear Stress System J Di Paola, AB Federici, PM Mannucci, MT Canciani, M Kritzik, TJ Kunicki, ... Blood, The Journal of the American Society of Hematology 93 (11), 3578-3582, 1999 | 163 | 1999 |
| Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels M Lavin, S Aguila, S Schneppenheim, N Dalton, KL Jones, JM O’Sullivan, ... Blood, The Journal of the American Society of Hematology 130 (21), 2344-2353, 2017 | 143 | 2017 |
| Platelet‐dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH I Bodó, J Eikenboom, R Montgomery, J Patzke, R Schneppenheim, ... Journal of Thrombosis and Haemostasis 13 (7), 1345-1350, 2015 | 142 | 2015 |
| Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation G Castaman, JCJ Eikenboom, RM Bertina, F Rodeghiero Thrombosis and haemostasis 82 (09), 1065-1070, 1999 | 133 | 1999 |
| Abnormal megakaryocyte development and platelet function in Nbeal2−/− mice WHA Kahr, RW Lo, L Li, FG Pluthero, H Christensen, R Ni, N Vaezzadeh, ... Blood, The Journal of the American Society of Hematology 122 (19), 3349-3358, 2013 | 131 | 2013 |
| Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor W Deng, Y Xu, W Chen, DS Paul, AK Syed, MA Dragovich, X Liang, ... Nature communications 7 (1), 12863, 2016 | 113 | 2016 |
| Significant gynecological bleeding in women with low von Willebrand factor levels M Lavin, S Aguila, N Dalton, M Nolan, M Byrne, K Ryan, B White, ... Blood advances 2 (14), 1784-1791, 2018 | 112 | 2018 |
| Glanzmann thrombasthenia: genetic basis and clinical correlates JP Botero, K Lee, BR Branchford, PF Bray, K Freson, MP Lambert, M Luo, ... Haematologica 105 (4), 888, 2020 | 101 | 2020 |
| Current therapy for rare factor deficiencies J Di Paola, D Nugent, G Young Haemophilia 7, 16-22, 2001 | 95 | 2001 |
| Sequential study of the histopathology and cellular and humoral immune response during the development of an autoimmune orchitis in Wistar rats GF DONCEL, JA DI PAOLA, L LUSTIG American journal of reproductive immunology 20 (2), 44-51, 1989 | 87 | 1989 |
| Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis BR Branchford, CJ Ng, KB Neeves, J Di Paola Thrombosis research 136 (1), 13-19, 2015 | 84 | 2015 |
| Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays KB Neeves, AA Onasoga, RR Hansen, JJ Lilly, D Venckunaite, ... PloS one 8 (1), e54680, 2013 | 82 | 2013 |
